Navigation Links
Medco Launches Medicare Part D Initiative to Promote ePrescribing
Date:2/12/2008

n; and

-- When a formulary alert was presented, 39 percent of the time the

physician changed the prescription to comply with formulary

requirements.

"The SEMI program results show that ePrescribing can have a big impact on patient safety and overall health care costs," continued Driscoll. "Medicare Part D provides the right opportunity to introduce many more physicians to ePrescribing, a key step toward improving patient safety for this critical segment of the population and reducing the cost of prescription health care in the Medicare program."

About Medco

Medco Health Solutions, Inc. (NYSE: MHS) is the nation's leading pharmacy benefit manager based on its 2006 total net revenues of more than $42 billion. Medco's prescription drug benefit programs, covering one in five Americans, are designed to drive down the cost of pharmacy health care for private and public employers, health plans, labor unions and government agencies of all sizes, and for individuals served by the Medicare Part D Prescription Drug Program. Medco, the world's most advanced pharmacy(TM) has created Therapeutic Resource Centers(TM) that are staffed with hundreds of specialist pharmacists trained and certified in specific chronic and complex conditions and have expertise in the medications that treat them. Medco is the nation's largest diabetes pharmacy care practice based on covered lives with the 2007 acquisition of the Liberty Medical, and the largest specialty pharmacy based on net revenues with the 2005 acquisition of Accredo Health, Incorporated. Medco is the highest-ranked independent pharmacy benefit manager on the 2007 Fortune 500 list. On the Net: http://www.medco.com.

<
'/>"/>
SOURCE Medco Health Solutions, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Medco Announces Date for Fourth-Quarter and Full-Year 2007 Financial Results
2. Medcos Specialized Pharmacists, Safety Programs Gain Therapy Management Accreditation
3. Medco CEO Reiterates Guidance, Positive Outlook for 2008
4. MedcomSoft Receives 2007s "Best in KLAS" EMR Ranking (1-5 Physicians)
5. MedcomSoft appoints former U.S. presidential health advisor, James Haveman, to health Care advisory board
6. URAC Names Medco as a Finalist in First-ever Best Practices in Consumer Empowerment and Protection Awards
7. Medco Announces Two-For-One Stock Split
8. Medco CEO to Present at the Merrill Lynch & Co., Inc. 2007 Health Services Investor Conference
9. Medco Elects Myrtle Potter, William Roper to Board of Directors
10. Medco to Build Worlds Largest, Most Advanced Automated Pharmacy in Central Indiana
11. Medco, LabCorp Strike Strategic Agreement for Research on Personalized Medicine and Pharmacogenomics

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)... Nov. 27 Preventing dis... fortunately every year, new vaccines are being ad...ccines boost immunity for the same period of time?...needed to keep immunity strong? ,, In this mo...ican Academy of Pediatrics, Michael Pichichero MD,...
(Date:11/27/2009)...-emission vehicles may reduce future disease burde...HealthDay News) -- Encouraging city dwellers to wa...uch greater public health benefits than increased ...ve found. , The study compared the projected he...nsport scenarios for London, England, and Delhi, I...
(Date:11/27/2009)...lti-purpose bilingual coloring books designed for ...iness community to educate - inform parents and ch...issues to Dinosuars to ABC,S and a host of other t...(PRWEB) November 27, 2009 -- Today’s childre... them busy any hour of the day, but one of the old...
(Date:11/26/2009)...., Nov. 27 The diabetes population...next 25 years and annual medical spending on the d...113 billion today, according to a study published ...ional Changing Diabetes ® Program (NCDP), a ... by a team from the University of Chicago. ,, A...
(Date:11/26/2009)...n on an emotional rollercoaster, study finds , ...l it the fear factor meets the jubilant sports fan...ecially those who root for the winning team -- enj...tested match and victory was in doubt, producing f...at this Thanksgiving weekend as you,re glued to th...
Breaking Medicine News(10 mins):Health News:Why Some Vaccines May Require A Booster 2Health News:Why Some Vaccines May Require A Booster 3Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 4Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3
...eilman Center,electro-mechanical manufacturing pla... a 2007 IndustryWeek magazine "Best Plant Finalist...e on the leading edge of efforts to,increase compe...09/MEDRADLOGO ) MEDRAD,s Heilman Center plant wa...
... patients, side effects impacting cognition don,t ...ng to a new survey, the cognitive impairment exper...be long-lasting and severely affect their personal...nize or multi-task have led to significant problem...
...7 The first significant genetic finding in premen...rted. PMDD is a very severe form of the more comm... heritable, affects 5-8% of women, and is associat... that quality of life is seriously impacted. Prev...
...Sales of World,s First Pocket Ultrasound ...if., Oct. 2 Siemens Medical,Solutions (http://ww...of medicine,with today,s launch of the world,s sma...1.6 pounds, and fits easily,into a lab coat pocket...
...imax GmbH, Campbell,CA, is pleased to announce tha...nc. the company is moving to larger premises in No...d. As of October 1st, 2007,joimax, Inc. will be lo...Michael Stek, CEO of the joimax, Inc. "Due to the ...
... Phylonix Pharmaceuticals, Inc. today announced t...l Business Innovation Grant (SBIR) from the Nation...lth (NIH) to develop zebrafish eye disease models ...onserved organ and the basic structure between hum...
Other Medicine News:Health News:MEDRAD Plant Named IndustryWeek Magazine Award Finalist 2Health News:MEDRAD Plant Named IndustryWeek Magazine Award Finalist 3Health News:Cognitive deficits lead to 'loss of self' among cancer patients 2Health News:First significant genetic finding in severe PMS, or PMDD 2Health News:Good Imaging Now Comes in the World's Smallest Ultrasound Package 2Health News:Good Imaging Now Comes in the World's Smallest Ultrasound Package 3Health News:NIH awards Phylonix phase II SBIR to develop zebrafish models for eye diseases 2
(Date:11/25/2009)..., WESTON, Fla., Nov. 25 /PRNewswire-FirstCall/ -... ASFX) ("the Company") is pleased to announce that...ion management office in Shanghai, China. ,, AS...ding an essential gateway for the development and ... products for children and adults to be distribute...
(Date:11/25/2009)...RINCETON, N.J., Nov. 25 ...e pharmaceutical company committed to discovering,...at viral infections, reported financial results fo...tember 30, 2009 Pharmasset held $58.4 million in c... ,, Pipeline Update and 2009 Highlights ,,...
(Date:11/25/2009)...XTON, Pa., Nov. 25 BioTrends Resea...nds(TM) : Stelara report, the first in a mult...g the launch of Centocor Ortho-Biotech,s Stelara, ...f availability. Each wave of the report provides ...ists and qualitative information from a subset of ...
Breaking Medicine Technology:American Scientific Resources Inc. Opens Shanghai Location 2Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Pharmasset Reports Fiscal Year End 2009 Financial Results 9Pharmasset Reports Fiscal Year End 2009 Financial Results 10Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2Iowa Drug Card a Huge Success With Iowans 55345 1Iowa Drug Card a Huge Success With Iowans 55345 2VA Chiefs Vow to The American Legion 3A We Will End Vet Homelessness 55343 1VA Chiefs Vow to The American Legion 3A We Will End Vet Homelessness 55343 2Mayo Clinic Proceedings 3A Common Blood Disorder May Not be Linked to as Many Serious Diseases as Previously Thought 55341 1Mayo Clinic Proceedings 3A Common Blood Disorder May Not be Linked to as Many Serious Diseases as Previously Thought 55341 2Mayo Clinic Proceedings 3A Common Blood Disorder May Not be Linked to as Many Serious Diseases as Previously Thought 55341 3
... out of ten patients taking,once-daily Lialda rema...TON, D.C., May 22, 2007 /PRNewswire-FirstCall/ -- ...nsion study (303),presented at the British Society...tland in March 2007 showed Shire plc,s,Lialda(mesa...atients. Today, secondary endpoints of study 303 w...
...tion in Risk of Hospitalization,from Crohn,s Disea... 22, 2007 /PRNewswire-FirstCall/ -- Abbott,today a...otal study,presented at the Digestive Disease Week...ts with moderate to severely active,Crohn,s diseas...therapy were almost 60 percent less likely than pa...
Other Medicine Technology:Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 2Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 3Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 4Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 5Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 6Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 7Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 8New Analysis of Data Shows Treatment With Abbott's Humira,(Adalimumab) Significantly Reduced Disease-Related Hospitalization,for Patients with Crohn's Disease 2New Analysis of Data Shows Treatment With Abbott's Humira,(Adalimumab) Significantly Reduced Disease-Related Hospitalization,for Patients with Crohn's Disease 3New Analysis of Data Shows Treatment With Abbott's Humira,(Adalimumab) Significantly Reduced Disease-Related Hospitalization,for Patients with Crohn's Disease 4New Analysis of Data Shows Treatment With Abbott's Humira,(Adalimumab) Significantly Reduced Disease-Related Hospitalization,for Patients with Crohn's Disease 5New Analysis of Data Shows Treatment With Abbott's Humira,(Adalimumab) Significantly Reduced Disease-Related Hospitalization,for Patients with Crohn's Disease 6New Analysis of Data Shows Treatment With Abbott's Humira,(Adalimumab) Significantly Reduced Disease-Related Hospitalization,for Patients with Crohn's Disease 7
Rheumatoid Factor Control
Microalbumin Urine Control
...he K-ASSAY Liquid Lipid Control is intended for us...sample of known concentration for monitoring assay...K-ASSAY Liquid Lipid Control with patient serum sp...tuents. The user can compare observations with exp...
Lyophilized ITA Control for K - ASSAY® Reagents
Medicine Products: